Clinical Trial: Contrast-Enhanced Stereotactic Biopsy
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Breast Cancer
Study Type: OBSERVATIONAL
Official Title: Assessing the Optimal Amount of Tissue Sampling in Contrast-Enhanced Stereotactic Biopsy (CESB)
Brief Summary:
Contrast-enhanced mammography (CEM) is an emerging breast imaging modality that is based on dual-energy mammography and the injection of iodinated contrast agent.A typical CEM study consists of a low-energy image (equal to a FFDM image) and a recombined image (in which areas of contrast enhancement can be appreciated).However, the situation can occur that lesions are visible only on the recombined (contrast) images (in this protocol defined as 'recombined-only lesions' or ROLs).In these cases,…
Read more